Hemolysis is the #1 source of preanalytical error and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary sample recollection, inefficient staff/nursing time and high costs.1–7 Hemolysis detection has not been available for blood gas testing until now. 

Our speakers will discuss hemolysis prevalence and impact throughout the hospital, and optimizing patient care and safety with integrated hemolysis detection at the point of care. Q&A to follow.

Date & Times:

February 10, 2025 : 10:00 AM–11:00 AM ET

Objectives

• Identify data and insights on the impact of hemolysis in whole blood potassium testing
• Outline the specific patient care impact of hemolysis in emergency and neonatal care
• Discuss the experience of adopting a new hemolysis detection technology and practice, to improve quality of care

Speakers

​

Marc Hoppenz, MD
Head of Division, Neonatology/Pediatric Intensive Care, Department of Pediatrics, Children's Hospital Cologne, Germany

Christian Neff, MD
Adjunct Assistant Professor, Dept of Emergency Medicine, University of Utah VP-CMO, Utah Emergency Physicians, Attending Physician, Intermountain Medical Center Salt Lake City, US

Gian Luca Salvagno, MD, PhD
Full Professor of Clinical Biochemistry, Department of Neurological, Biomedical and Movement Sciences, University of Verona Director, Clinical Laboratory, Pederzoli-Peschiera Hospital Verona, Italy

Danyel Tacker, PhD, D(ABCC), FAACC
Clinical Professor of Pathology, West Virginia University, Associate Medical Director of Clinical Laboratories, West Virginia University Hospital Morgantown, WV, US